5-(4'-Substituted-2'-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators. I

European Journal of Medicinal Chemistry

Volumn 35, Issue 7-8, 2000, Pages 715-720

  Biagi, Giuliana ^a   Calderone, Vincenzo ^a   Giorgi, Irene ^a   Livi, Oreste ^a   Scartoni, Valerio ^a   Baragatti, Barbara ^b   Martinotti, Enrica ^b  

^a UNIVERSITY OF PISA   (Italy)

^b Dipartimento di Psichiatria Neurobiologia   (Italy)

Author keywords

1,2,3 triazoles; Potassium channel activators

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 1 (5 CHLORO 2 HYDROXYPHENYL) 5 TRIFLUOROMETHYL 2 BENZIMIDAZOLONE; 1,2,3 TRIAZOLE DERIVATIVE; 4 AMINOPYRIDINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CONDUCTANCE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOTHELIUM; ISOMERISM; MEMBRANE DEPOLARIZATION; NONHUMAN; RAT; VASODILATATION;

EID: 0033914101     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00180-X     Document Type: Article

References (17)

1. Biagi G., Giorgi I., Livi O., Scartoni V., Velo S., Barili P.L. J. Heterocycl. Chem. 33:1996;1847-1853.
2. Bertelli L., Biagi G., Calderone V., Giorgi I., Livi O., Scartoni V., Barili P.L. J. Heterocycl. Chem. in press.
3. Olesen S.P., Jensen L.H., Moldt P., European Patent Application (1974), EPA 617023.
4. Cook N.S. Potassium Channels: Structure, Classification, Function and Therapeutic Potential. 1990;Ellis Horwood Ltd, Southampton.
5. Calderone V., Nieri P., Baragatti B., Martinotti E., Livi O., 6th Joint Meeting of the Italian, Hungarian and Polish Pharmacological Societies, May 14-16, 1998, Pisa, p. 46.
6. Smith P.A.S., Boyer J.H. Benzofurazan oxide. Schreiber R.S. Organic Syntheses. 1951;14-16 Wiley, NY.
7. Tanaka Y., Velen S.R., Miller S.I. Tetrahedron. 29:1973;3271-3283.
8. Dyall L.K., Kemp J.E. Aust. J. Chem. 20:1967;1395-1402.
9. Dyall L.K. Aust. J. Chem. 39:1986;89-101.
10. Ghosh P.B., Ternai B., Whitehouse M.W. J. Med. Chem. 15:1972;255-260.
11. Vandier C., Bonnet P. Eur. J. Pharmacol. 295:1996;53-60.
12. Edwards G., Niederste-Hollenberg A., Schneider J., Noack T., Weston A.H. Br. J. Pharmacol. 113:1994;1538-1547.
13. Sargent C.A., Grover G.J., Antonaccio M.J., McCullough J.R. J. Pharmacol. Exp. Ther. 266:1993;1422-1429.
14. Magnon M., Calderone V., Floch A., Cavero I. Naunyn Schmiedeberg's Arch. Pharmacol. 358:1998;452-463.
15. Reilly J., Hickinbottom W.J. J. Chem. Soc. 117:1920;103-137.
16. Itaya M., Takai Y., Suzuki K., Yakugaku Zasshi 81 (1961) 921-923; Chem. Abstr. 56 (1962) 3405
17. Itaya M., Takai Y., Suzuki K., Yakugaku Zasshi 81 (1961) 921-923; Chem. Abstr. 56 (1962) 3405.